These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35602773)

  • 1. Baseline Characteristics Associated With Sodium-Glucose Cotransporter Inhibitor Prescriptions in Type 2 Diabetic Patients in Jazan, Saudi Arabia.
    Somaili M; Oraibi O; Mohrag M; Hommadi A; Moafa E; Kulaybi A; Shobayli S; Moafa R; Mhgfory G; Jaafari A; Shami A; Majrashi K
    Cureus; 2022 Apr; 14(4):e24284. PubMed ID: 35602773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Care Gaps in Sodium-Glucose Cotransporter-2 Inhibitor and Renin Angiotensin System Inhibitor Prescriptions for Patients with Diabetic Kidney Disease.
    Rikin S; Deccy S; Zhang C; Crandall J; Deng Y; Golestaneh L
    J Gen Intern Med; 2023 May; 38(7):1599-1605. PubMed ID: 36352203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Outcomes in Patients with Diabetes Mellitus and Heart Failure.
    Hofer F; Kazem N; Richter B; Sulzgruber P; Schweitzer R; Pailer U; Hammer A; Koller L; Hengstenberg C; Niessner A
    Cardiovasc Drugs Ther; 2022 Jun; 36(3):497-504. PubMed ID: 34342791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge, Attitude, and Practice around Diabetic Eye Disease among Diabetic Patients in Jazan Region, Saudi Arabia.
    Najmi H; Otaif W; Najmi M; Basehi M; Tobaigy M; Alsalim W; Awaji M; Najmi A
    Middle East Afr J Ophthalmol; 2021; 28(2):123-128. PubMed ID: 34759671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors.
    Ling AW; Chan CC; Chen SW; Kao YW; Huang CY; Chan YH; Chu PH
    Cardiovasc Diabetol; 2020 Nov; 19(1):188. PubMed ID: 33158436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of sodium glucose cotransporter 2 inhibitors on left ventricular mass in patients with diabetes mellitus.
    Kosugi D; Inaba H; Kaido Y; Ito S; Hirobata T; Toyofuku M; Matsuoka T; Inoue G
    J Diabetes; 2021 Nov; 13(11):847-856. PubMed ID: 34231959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incident heart failure and myocardial infarction in sodium-glucose cotransporter-2 vs. dipeptidyl peptidase-4 inhibitor users.
    Zhou J; Lee S; Leung KSK; Wai AKC; Liu T; Liu Y; Chang D; Wong WT; Wong ICK; Cheung BMY; Zhang Q; Tse G
    ESC Heart Fail; 2022 Apr; 9(2):1388-1399. PubMed ID: 35132823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Coronary Artery Disease.
    Hofer F; Kazem N; Schweitzer R; Hammer A; Jakse F; Koller L; Hengstenberg C; Sulzgruber P; Niessner A
    Cardiovasc Drugs Ther; 2021 Dec; 35(6):1161-1170. PubMed ID: 33666822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D deficiency and glycemic control among patients with type 2 diabetes mellitus in Jazan City, Saudi Arabia.
    Darraj H; Badedi M; Poore KR; Hummadi A; Khawaji A; Solan Y; Zakri I; Sabai A; Darraj M; Mutawwam DA; Daghreeri M; Sayed S; Alaallah W; Alfadhly A; Alsabaani A
    Diabetes Metab Syndr Obes; 2019; 12():853-862. PubMed ID: 31239741
    [No Abstract]   [Full Text] [Related]  

  • 10. Tuberculosis among people living with HIV/AIDS in Jazan Region, Southwestern Saudi Arabia.
    Darraj MA; Abdulhaq AA; Yassin A; Mubarki S; Shalaby HM; Keynan Y; Ghailan KY; Al-Mekhlafi HM
    J Infect Public Health; 2021 Nov; 14(11):1571-1577. PubMed ID: 34656963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription patterns of diabetes medications influencing clinical outcomes of heart failure patients with reduced ejection fraction.
    Chang HY; Su YW; Feng AN; Fong MC; Huang KC; Chong E; Chen KC; Yin WH
    ESC Heart Fail; 2020 Apr; 7(2):604-615. PubMed ID: 31995274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Baseline Clinical Variables on SGLT2i's Antiproteinuric Effect in Diabetic Kidney Disease.
    Capelli I; Ribichini D; Provenzano M; Vetrano D; Aiello V; Cianciolo G; Vicennati V; Tomassetti A; Moschione G; Berti S; Pagotto U; La Manna G
    Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoption of New Glucose-Lowering Medications in the U.S.-The Case of SGLT2 Inhibitors: Nationwide Cohort Study.
    McCoy RG; Dykhoff HJ; Sangaralingham L; Ross JS; Karaca-Mandic P; Montori VM; Shah ND
    Diabetes Technol Ther; 2019 Dec; 21(12):702-712. PubMed ID: 31418588
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of weight loss related to risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium-glucose cotransporter 2 inhibitor.
    Chan YH; Chen SW; Chao TF; Kao YW; Huang CY; Chu PH
    Cardiovasc Diabetol; 2021 Apr; 20(1):93. PubMed ID: 33941171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of diabetic retinopathy in type 2 diabetes mellitus patients in Makkah Al-Mukarramah, Saudi Arabia.
    Bajaber BA; Alshareef MA
    J Family Community Med; 2021; 28(1):8-16. PubMed ID: 33679184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of consequent nephropathy following initial weight loss in diabetic patients treated with sodium glucose cotransporter 2 inhibitors.
    Chan YH; Chen SW; Chao TF; Kao YW; Huang CY; Chu PH
    Cardiovasc Diabetol; 2021 Aug; 20(1):167. PubMed ID: 34399757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing Patients' Utilization of Dental Health Services in Jazan, Kingdom of Saudi Arabia.
    Quadri FA; Jafari FA; Albeshri AT; Zailai AM
    Int J Clin Pediatr Dent; 2018; 11(1):29-33. PubMed ID: 29805231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium glucose cotransporter-2 inhibitor was associated with an improvement in left ventricular systolic function in patients with type 2 diabetes mellitus with impaired left ventricular systolic function.
    Chan YH; Hsu TJ; Wang CL; Kao YW; Huang CY; Chu PH
    ESC Heart Fail; 2020 Oct; 7(5):2784-2796. PubMed ID: 32627380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia.
    Alzaheb RA; Altemani AH
    Diabetes Metab Syndr Obes; 2018; 11():15-21. PubMed ID: 29430192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Khat Chewing and Type 2 Diabetes Mellitus.
    Badedi M; Darraj H; Hummadi A; Najmi A; Solan Y; Zakry I; Khawaji A; Zaylai S; Rajeh N; Alhafaf H; Hakami W; Bakkari A; Kriry M; Dagreri A; Haddad E
    Diabetes Metab Syndr Obes; 2020; 13():307-312. PubMed ID: 32104027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.